RU2013142066A - Способы и композиции для получения персонифицированных мультипотентных нейрональных стволовых клеток - Google Patents
Способы и композиции для получения персонифицированных мультипотентных нейрональных стволовых клеток Download PDFInfo
- Publication number
- RU2013142066A RU2013142066A RU2013142066/10A RU2013142066A RU2013142066A RU 2013142066 A RU2013142066 A RU 2013142066A RU 2013142066/10 A RU2013142066/10 A RU 2013142066/10A RU 2013142066 A RU2013142066 A RU 2013142066A RU 2013142066 A RU2013142066 A RU 2013142066A
- Authority
- RU
- Russia
- Prior art keywords
- stem cell
- neuronal stem
- neuronal
- neuron
- cells
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims 31
- 239000000203 mixture Substances 0.000 title 1
- 210000001178 neural stem cell Anatomy 0.000 title 1
- 230000001537 neural effect Effects 0.000 claims abstract 107
- 210000000130 stem cell Anatomy 0.000 claims abstract 92
- 210000002569 neuron Anatomy 0.000 claims abstract 36
- 210000000287 oocyte Anatomy 0.000 claims abstract 12
- 210000001130 astrocyte Anatomy 0.000 claims abstract 6
- 230000008774 maternal effect Effects 0.000 claims abstract 6
- 210000004248 oligodendroglia Anatomy 0.000 claims abstract 6
- 210000004498 neuroglial cell Anatomy 0.000 claims abstract 4
- 102100035416 Forkhead box protein O4 Human genes 0.000 claims abstract 3
- 101000877683 Homo sapiens Forkhead box protein O4 Proteins 0.000 claims abstract 3
- 101000979001 Homo sapiens Methionine aminopeptidase 2 Proteins 0.000 claims abstract 3
- 101000969087 Homo sapiens Microtubule-associated protein 2 Proteins 0.000 claims abstract 3
- 101000687905 Homo sapiens Transcription factor SOX-2 Proteins 0.000 claims abstract 3
- 101000713575 Homo sapiens Tubulin beta-3 chain Proteins 0.000 claims abstract 3
- -1 Mushashi-1 Proteins 0.000 claims abstract 3
- 108010088225 Nestin Proteins 0.000 claims abstract 3
- 102100024270 Transcription factor SOX-2 Human genes 0.000 claims abstract 3
- 102100036790 Tubulin beta-3 chain Human genes 0.000 claims abstract 3
- 210000005055 nestin Anatomy 0.000 claims abstract 3
- 102000054766 genetic haplotypes Human genes 0.000 claims abstract 2
- 210000004027 cell Anatomy 0.000 claims 15
- 239000002609 medium Substances 0.000 claims 11
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims 6
- 229940009444 amphotericin Drugs 0.000 claims 6
- 238000012258 culturing Methods 0.000 claims 6
- 210000005064 dopaminergic neuron Anatomy 0.000 claims 6
- 210000002950 fibroblast Anatomy 0.000 claims 6
- 230000006698 induction Effects 0.000 claims 6
- 230000004069 differentiation Effects 0.000 claims 5
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 claims 4
- 208000024827 Alzheimer disease Diseases 0.000 claims 4
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 claims 4
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims 4
- 208000012902 Nervous system disease Diseases 0.000 claims 4
- 208000027418 Wounds and injury Diseases 0.000 claims 4
- 239000000654 additive Substances 0.000 claims 4
- 230000000996 additive effect Effects 0.000 claims 4
- 230000006378 damage Effects 0.000 claims 4
- 208000014674 injury Diseases 0.000 claims 4
- 230000035755 proliferation Effects 0.000 claims 4
- 102100024014 Nestin Human genes 0.000 claims 3
- 210000002932 cholinergic neuron Anatomy 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 210000001222 gaba-ergic neuron Anatomy 0.000 claims 3
- 210000001362 glutamatergic neuron Anatomy 0.000 claims 3
- 235000015097 nutrients Nutrition 0.000 claims 3
- 230000000862 serotonergic effect Effects 0.000 claims 3
- 208000017194 Affective disease Diseases 0.000 claims 2
- 102100035248 Alpha-(1,3)-fucosyltransferase 4 Human genes 0.000 claims 2
- 208000019901 Anxiety disease Diseases 0.000 claims 2
- 208000020925 Bipolar disease Diseases 0.000 claims 2
- 206010010904 Convulsion Diseases 0.000 claims 2
- 206010012289 Dementia Diseases 0.000 claims 2
- 206010012335 Dependence Diseases 0.000 claims 2
- 208000020401 Depressive disease Diseases 0.000 claims 2
- 208000014094 Dystonic disease Diseases 0.000 claims 2
- 102100039289 Glial fibrillary acidic protein Human genes 0.000 claims 2
- 101710193519 Glial fibrillary acidic protein Proteins 0.000 claims 2
- 101001022185 Homo sapiens Alpha-(1,3)-fucosyltransferase 4 Proteins 0.000 claims 2
- 101001023712 Homo sapiens Nectin-3 Proteins 0.000 claims 2
- 208000023105 Huntington disease Diseases 0.000 claims 2
- 206010021118 Hypotonia Diseases 0.000 claims 2
- 206010021143 Hypoxia Diseases 0.000 claims 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims 2
- 229930182816 L-glutamine Natural products 0.000 claims 2
- 102100023174 Methionine aminopeptidase 2 Human genes 0.000 claims 2
- 208000019695 Migraine disease Diseases 0.000 claims 2
- 208000019022 Mood disease Diseases 0.000 claims 2
- 208000019430 Motor disease Diseases 0.000 claims 2
- 102100035487 Nectin-3 Human genes 0.000 claims 2
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 claims 2
- 208000002193 Pain Diseases 0.000 claims 2
- 208000018737 Parkinson disease Diseases 0.000 claims 2
- 206010039966 Senile dementia Diseases 0.000 claims 2
- 208000006011 Stroke Diseases 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims 2
- 230000036506 anxiety Effects 0.000 claims 2
- 208000028683 bipolar I disease Diseases 0.000 claims 2
- 210000004556 brain Anatomy 0.000 claims 2
- 208000029028 brain injury Diseases 0.000 claims 2
- 239000006285 cell suspension Substances 0.000 claims 2
- 230000036461 convulsion Effects 0.000 claims 2
- 208000010118 dystonia Diseases 0.000 claims 2
- 201000003104 endogenous depression Diseases 0.000 claims 2
- 206010015037 epilepsy Diseases 0.000 claims 2
- 210000005046 glial fibrillary acidic protein Anatomy 0.000 claims 2
- 208000028867 ischemia Diseases 0.000 claims 2
- 238000002955 isolation Methods 0.000 claims 2
- 238000012423 maintenance Methods 0.000 claims 2
- 208000024714 major depressive disease Diseases 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 230000035800 maturation Effects 0.000 claims 2
- 206010027599 migraine Diseases 0.000 claims 2
- 201000006417 multiple sclerosis Diseases 0.000 claims 2
- 230000036640 muscle relaxation Effects 0.000 claims 2
- 230000003961 neuronal insult Effects 0.000 claims 2
- 231100000189 neurotoxic Toxicity 0.000 claims 2
- 230000002887 neurotoxic effect Effects 0.000 claims 2
- 210000001778 pluripotent stem cell Anatomy 0.000 claims 2
- 201000000980 schizophrenia Diseases 0.000 claims 2
- 208000019116 sleep disease Diseases 0.000 claims 2
- 208000020431 spinal cord injury Diseases 0.000 claims 2
- 239000013589 supplement Substances 0.000 claims 2
- 208000030507 AIDS Diseases 0.000 claims 1
- 206010002660 Anoxia Diseases 0.000 claims 1
- 241000976983 Anoxia Species 0.000 claims 1
- 206010003497 Asphyxia Diseases 0.000 claims 1
- 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 claims 1
- 208000000094 Chronic Pain Diseases 0.000 claims 1
- 102000006311 Cyclin D1 Human genes 0.000 claims 1
- 108010058546 Cyclin D1 Proteins 0.000 claims 1
- 201000010374 Down Syndrome Diseases 0.000 claims 1
- 206010013647 Drowning Diseases 0.000 claims 1
- 102100037362 Fibronectin Human genes 0.000 claims 1
- 108010067306 Fibronectins Proteins 0.000 claims 1
- 108010010803 Gelatin Proteins 0.000 claims 1
- 101100238555 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) msbA gene Proteins 0.000 claims 1
- 101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 claims 1
- 101001020544 Homo sapiens LIM/homeobox protein Lhx2 Proteins 0.000 claims 1
- 101001111320 Homo sapiens Nestin Proteins 0.000 claims 1
- 101000979249 Homo sapiens Neuromodulin Proteins 0.000 claims 1
- 102100036132 LIM/homeobox protein Lhx2 Human genes 0.000 claims 1
- 108010085895 Laminin Proteins 0.000 claims 1
- 208000005314 Multi-Infarct Dementia Diseases 0.000 claims 1
- 206010028923 Neonatal asphyxia Diseases 0.000 claims 1
- 208000037212 Neonatal hypoxic and ischemic brain injury Diseases 0.000 claims 1
- 102100023206 Neuromodulin Human genes 0.000 claims 1
- 208000026251 Opioid-Related disease Diseases 0.000 claims 1
- 208000004224 Opium Dependence Diseases 0.000 claims 1
- 108010032788 PAX6 Transcription Factor Proteins 0.000 claims 1
- 102100037506 Paired box protein Pax-6 Human genes 0.000 claims 1
- 241000282898 Sus scrofa Species 0.000 claims 1
- 201000004810 Vascular dementia Diseases 0.000 claims 1
- 230000001154 acute effect Effects 0.000 claims 1
- 208000005298 acute pain Diseases 0.000 claims 1
- 230000007953 anoxia Effects 0.000 claims 1
- 229940125717 barbiturate Drugs 0.000 claims 1
- 231100000045 chemical toxicity Toxicity 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 230000009429 distress Effects 0.000 claims 1
- 206010013663 drug dependence Diseases 0.000 claims 1
- 208000024732 dysthymic disease Diseases 0.000 claims 1
- 229920000159 gelatin Polymers 0.000 claims 1
- 239000008273 gelatin Substances 0.000 claims 1
- 235000019322 gelatine Nutrition 0.000 claims 1
- 235000011852 gelatine desserts Nutrition 0.000 claims 1
- 230000002218 hypoglycaemic effect Effects 0.000 claims 1
- 230000007954 hypoxia Effects 0.000 claims 1
- 108010082117 matrigel Proteins 0.000 claims 1
- 230000027939 micturition Effects 0.000 claims 1
- 208000008013 morphine dependence Diseases 0.000 claims 1
- 208000010125 myocardial infarction Diseases 0.000 claims 1
- 230000004770 neurodegeneration Effects 0.000 claims 1
- 208000033300 perinatal asphyxia Diseases 0.000 claims 1
- 230000000698 schizophrenic effect Effects 0.000 claims 1
- 230000001932 seasonal effect Effects 0.000 claims 1
- 239000000758 substrate Substances 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 102100021118 Microtubule-associated protein 2 Human genes 0.000 abstract 1
- 102000008730 Nestin Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0619—Neurons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/46—Amines, e.g. putrescine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/235—Leukemia inhibitory factor [LIF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/04—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from germ cells
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Developmental Biology & Embryology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychology (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161442711P | 2011-02-14 | 2011-02-14 | |
| US61/442,711 | 2011-02-14 | ||
| PCT/US2012/025134 WO2012112620A1 (en) | 2011-02-14 | 2012-02-14 | Methods and compositions of producing patient-specific multipotent neuronal stem cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2013142066A true RU2013142066A (ru) | 2015-03-27 |
Family
ID=46672927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2013142066/10A RU2013142066A (ru) | 2011-02-14 | 2012-02-14 | Способы и композиции для получения персонифицированных мультипотентных нейрональных стволовых клеток |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20130045187A1 (https=) |
| EP (1) | EP2675892A4 (https=) |
| JP (1) | JP2014509192A (https=) |
| KR (1) | KR20140008369A (https=) |
| CN (1) | CN103415614A (https=) |
| CA (1) | CA2827288A1 (https=) |
| IL (1) | IL227919A0 (https=) |
| MX (1) | MX2013009395A (https=) |
| RU (1) | RU2013142066A (https=) |
| SG (1) | SG192732A1 (https=) |
| WO (1) | WO2012112620A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016508520A (ja) * | 2013-02-15 | 2016-03-22 | インターナショナル ステム セル コーポレイション | 神経変性疾患の治療のための、ヒト多能性幹細胞に由来する神経細胞の使用 |
| KR20140121317A (ko) * | 2013-04-06 | 2014-10-15 | 서울대학교산학협력단 | 비신경 세포로부터 유도 신경 줄기 세포의 생산 방법 및 이에 의하여 생산되는 유도 신경 줄기 세포 |
| WO2015181253A1 (en) * | 2014-05-27 | 2015-12-03 | Fundación Pública Andaluza Progreso Y Salud | Neural progenitor cell population |
| EP3279318A4 (en) * | 2015-03-30 | 2018-08-29 | Ajinomoto Co., Inc. | Human serum albumin-containing culture medium for growth of neural stem cells |
| KR101705245B1 (ko) * | 2015-05-22 | 2017-02-09 | 건국대학교 글로컬산학협력단 | 마트리겔이 코팅된 신경줄기세포 배양용 플레이트 |
| JP6680479B2 (ja) | 2015-06-29 | 2020-04-15 | 株式会社片岡製作所 | 細胞処理方法、レーザ加工機 |
| CN109069870B (zh) | 2016-02-24 | 2022-04-29 | 洛克菲勒大学 | 基于胚胎细胞的用于亨廷顿氏病的治疗候选物筛选系统、模型及它们的应用 |
| JP6033980B1 (ja) | 2016-06-01 | 2016-11-30 | 株式会社片岡製作所 | 細胞処理システム |
| JP6532063B2 (ja) | 2017-02-13 | 2019-06-19 | 株式会社片岡製作所 | 細胞処理装置 |
| JP6541160B2 (ja) | 2017-02-13 | 2019-07-10 | 株式会社片岡製作所 | 細胞処理装置および対象物の処理方法 |
| US10767164B2 (en) | 2017-03-30 | 2020-09-08 | The Research Foundation For The State University Of New York | Microenvironments for self-assembly of islet organoids from stem cells differentiation |
| SG11202012141WA (en) * | 2018-06-06 | 2021-01-28 | Univ California | Neural stem cell compositions and methods to treat neurodegenerative disorders |
| JP6574028B1 (ja) | 2018-06-29 | 2019-09-11 | 株式会社片岡製作所 | 細胞処理装置および細胞のレーザ処理方法 |
| JP6732313B2 (ja) | 2018-10-01 | 2020-07-29 | 株式会社片岡製作所 | 細胞培養器具および細胞培養器具の製造方法 |
| JP7343119B2 (ja) | 2019-04-26 | 2023-09-12 | 株式会社片岡製作所 | 細胞培養基材、細胞培養容器、細胞の培養方法、細胞の製造方法、細胞培養基材の製造方法、および細胞培養容器の製造方法 |
| EP4163360A4 (en) | 2020-06-22 | 2024-05-01 | Kataoka Corporation | CELL TREATMENT DEVICE, LEARNING DEVICE AND LEARNED MODEL PROPOSAL DEVICE |
| WO2022110180A1 (en) * | 2020-11-30 | 2022-06-02 | Zhejiang Huode Bioengineering Company Limited | Generation of neural progenitor cells from embryonic stem cells or induced pluripotent stem cells |
| EP4579589A1 (en) * | 2023-02-07 | 2025-07-02 | Kataoka Corporation | Apparatus for producing identifier for use in cell classification, identifier for use in cell classification, cell classification apparatus, and cell treatment system |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6680199B1 (en) * | 1993-02-10 | 2004-01-20 | Infigen, Inc. | In vitro activation of mammalian oocytes |
| US20040091936A1 (en) * | 2002-05-24 | 2004-05-13 | Michael West | Bank of stem cells for producing cells for transplantation having HLA antigens matching those of transplant recipients, and methods for making and using such a stem cell bank |
| US7732202B2 (en) * | 2005-10-21 | 2010-06-08 | International Stem Cell Corporation | Oxygen tension for the parthenogenic activation of human oocytes for the production of human embryonic stem cells |
| US20080124276A1 (en) * | 2006-07-24 | 2008-05-29 | Lifeline Cell Technology | Synthetic cornea from retinal stem cells |
| US20080206204A1 (en) * | 2007-02-27 | 2008-08-28 | Tiziana Brevini | Human parthenogenetic stem cells |
| CA2683060C (en) * | 2007-04-06 | 2018-01-16 | International Stem Cell Corporation | Patient-specific stem cell lines derived from human parthenogenetic blastocysts |
| US20110052548A1 (en) * | 2009-08-27 | 2011-03-03 | The Regents Of The University Of California | Cell culture media to differentiate embryonic stem cells into neuronal lineages |
-
2012
- 2012-02-14 WO PCT/US2012/025134 patent/WO2012112620A1/en not_active Ceased
- 2012-02-14 US US13/396,560 patent/US20130045187A1/en not_active Abandoned
- 2012-02-14 MX MX2013009395A patent/MX2013009395A/es unknown
- 2012-02-14 CA CA2827288A patent/CA2827288A1/en not_active Abandoned
- 2012-02-14 KR KR1020137024007A patent/KR20140008369A/ko not_active Withdrawn
- 2012-02-14 SG SG2013061171A patent/SG192732A1/en unknown
- 2012-02-14 EP EP12747027.6A patent/EP2675892A4/en not_active Withdrawn
- 2012-02-14 CN CN2012800119679A patent/CN103415614A/zh active Pending
- 2012-02-14 RU RU2013142066/10A patent/RU2013142066A/ru unknown
- 2012-02-14 JP JP2013553665A patent/JP2014509192A/ja active Pending
-
2013
- 2013-08-11 IL IL227919A patent/IL227919A0/en unknown
-
2015
- 2015-01-07 US US14/591,764 patent/US20150147301A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| MX2013009395A (es) | 2014-03-27 |
| EP2675892A4 (en) | 2014-11-05 |
| WO2012112620A1 (en) | 2012-08-23 |
| EP2675892A1 (en) | 2013-12-25 |
| IL227919A0 (en) | 2013-09-30 |
| US20150147301A1 (en) | 2015-05-28 |
| CA2827288A1 (en) | 2012-08-23 |
| KR20140008369A (ko) | 2014-01-21 |
| CN103415614A (zh) | 2013-11-27 |
| US20130045187A1 (en) | 2013-02-21 |
| SG192732A1 (en) | 2013-09-30 |
| JP2014509192A (ja) | 2014-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2013142066A (ru) | Способы и композиции для получения персонифицированных мультипотентных нейрональных стволовых клеток | |
| JP2014509192A5 (https=) | ||
| Jiang et al. | Adult rat mesenchymal stem cells differentiate into neuronal-like phenotype and express a variety of neuro-regulatory molecules in vitro | |
| JP5690066B2 (ja) | ヒト胚性幹細胞から、高収率で、神経前駆細胞、神経細胞及び機能性ドーパミン神経細胞を生成する方法 | |
| Schwartz et al. | Differentiation of neural lineage cells from human pluripotent stem cells | |
| CN1662645B (zh) | 神经细胞的制备方法 | |
| WO2011028524A1 (en) | Substantially pure human retinal progenitor, forebrain progenitor, and retinal pigment epithelium cell cultures and methods of making the same | |
| US10231999B2 (en) | Process for preparing cholinergic neurons | |
| KR20230165846A (ko) | 도파민성 전구세포 및 사용 방법 | |
| Wang et al. | Chemical conversion of mouse fibroblasts into functional dopaminergic neurons | |
| US10472607B2 (en) | Culture medium and method for inducing differentiation of pluripotent stem cells into neuroepithelial cells | |
| Jiang et al. | Specification of functional neurons and glia from human pluripotent stem cells | |
| Kim et al. | Derivation of functional dopamine neurons from embryonic stem cells | |
| EP1705245B1 (en) | Neural stem cells | |
| US10760051B2 (en) | Process for preparing astrocytes | |
| CN112553160B (zh) | 一种化学诱导皮质神经元的方法及培养基 | |
| CN103305458B (zh) | 从多潜能干细胞诱导胆碱能神经元的方法 | |
| Boote Jones et al. | Directed growth and differentiation of stem cells towards neural cell fates using soluble and surface-mediated cues | |
| Enderami et al. | Enhanced yield of cholinergic neurons from induced pluripotent stem cells (iPSC): A two-step induction protocol. | |
| KR100856706B1 (ko) | 혈관내피 성장인자를 이용한 인간배아 줄기세포로부터도파민 신경세포로의 분화 촉진 방법 | |
| CN115141803B (zh) | 使用人多潜能干细胞诱导获得脊髓谷氨酸能中间神经元的方法及其应用 | |
| Zhang | Differentiating Human Stem Cells to Neurons | |
| US20190322982A1 (en) | Stem Cells from the Mammalian Neural Plate | |
| Brennand et al. | Comprehensive Developmental Neuroscience: Patterning and Cell Type Specification in the Developing CNS and PNS: Chapter 6. Neural Induction of Embryonic Stem/Induced Pluripotent Stem Cells | |
| Du et al. | Effect of monolayer cells on sphere cells—Two types of cells that emerge during the neural differentiation of mouse embryonic stem cells |